drugset
drugset / Trial / NCT01043263

Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain

NCT01043263 ↗

Phase 2 Completed 236 enrolled Grünenthal GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of EN3324 (axomadol) in subjects with moderate to severe chronic low back pain

Timeline

Start
2009-12
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject axomadol Unknown — —

Indications

chronic pain syndrome